Mark Eric Kohler

9PUBLICATIONS
64CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 01, 2026
FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.

|Jun 10, 2026
Multiple Myeloma Cells Resistant to T-cell Therapies Exhibit a CD45+ Immunoevasive Phenotype.

|Nov 14, 2025
Increased NFAT activity with dual CAR stimulation in CD19xCD22 CAR T-cells is associated with decreased exhaustion and improved survival.

Alexander W Rankin, Catherine Pham-Danis, Amanda J Novak

|Aug 19, 2025
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML.

Swati Naik, Richard Aplenc, Susanne H C Baumeister

|Apr 17, 2025
T-bet overexpression enhances CAR T cell effector functions and antigen sensitivity.

Jennifer M Cimons, Kole R DeGolier, Samuel D Burciaga

|Jan 02, 2025
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response.

Kole R DeGolier, Etienne Danis, Marc D'Antonio

Pageof 2

Frequent Collaborators

4 joint publications

Amanda J Novak

3 joint publications

Jennifer M Cimons

2 joint publications

Angelo D'Alessandro

2 joint publications

Michael Yarnell